The PFS survival curve is exhibited in Figure 4, and the median PFS of the 68 elderly patients with advanced NSCLC who received PD-1 inhibitor monotherapy was 3.5 months (95%CI: 2.38–4.62). Here, PDCD1 is linked to non-small cell lung carcinoma.